0000899243-22-021396.txt : 20220607 0000899243-22-021396.hdr.sgml : 20220607 20220607193748 ACCESSION NUMBER: 0000899243-22-021396 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220606 FILED AS OF DATE: 20220607 DATE AS OF CHANGE: 20220607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lo Steven CENTRAL INDEX KEY: 0001501959 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36570 FILM NUMBER: 221002313 MAIL ADDRESS: STREET 1: C/O CORCEPT THERAPEUTICS STREET 2: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zosano Pharma Corp CENTRAL INDEX KEY: 0001587221 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454488360 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34790 ARDENTECH COURT CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-1200 MAIL ADDRESS: STREET 1: 34790 ARDENTECH COURT CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: ZP Holdings Inc DATE OF NAME CHANGE: 20130919 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-06 0 0001587221 Zosano Pharma Corp ZSAN 0001501959 Lo Steven C/O ZOSANO PHARMA CORPORATION 34790 ARDENTECH COURT FREMONT CA 94555 1 1 0 0 Chief Executive Officer Common Stock 2022-06-06 4 S 0 442 0.71 D 13163 D The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer. Reflects a 1-for-35 reverse stock split of the Issuer's common stock, effected on April 11, 2022. /s/ Steven Lo 2022-06-07